# A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

> **NCT06854952** · PHASE2 · COMPLETED · sponsor: **Terns, Inc.** · enrollment: 167 (actual)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DRUG:** TERN-601
- **OTHER:** Matching Placebo

## Key facts

- **NCT ID:** NCT06854952
- **Lead sponsor:** Terns, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-07
- **Primary completion:** 2025-08-19
- **Final completion:** 2025-09-19
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06854952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06854952, "A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06854952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*